CIE-10

CIE-10-código E22.0

You are here: Inicio > CIE-10 > E00-E89 > E20-E35 > E22

- CIE-10
Clasificación Internacional de Enfermedades
- E00-E89
Enfermedades endocrinas, nutricionales y metabolicas
- E20-E35
Trastornos de otras glándulas endocrinas
- E22
Hiperfunción de la glándula hipófisis

E22.0

Acromegalia y gigantismo hipofisario

CIE-10 Сódigo E22.0 para Acromegalia y gigantismo hipofisario

Artropatía asociada con acromegalia (M14.5)

Sobreproducción de hormona del crecimiento

Excluye: aumento de la secreción por el páncreas endocrino de la hormona liberadora de la hormona del crecimiento (E16.8)

estatura alta constitucional (E34.4)

gigantismo constitucional (E34.4)

ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us